Vascular Biogenics Ltd.

(VBLT) Trade

By |

Profile

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.

Contact Information

Website: www.vblrx.com
Email: IR@VBLRX.COM
Main Phone: +972 89935000
Address: 8 HaSatat Street
City / Town: Modi'in
Country: ISR
Postal Code: 7178106

Issuer Information

Exchange: NSD
CEO: Dror Harats
Employees: 37
NAICS: Pharmaceutical P
$ 1.14 $ -0.01 (-0.87%)
Last Price 1.14 Change $ -0.01 Change % -0.87 Tick N/A
Bid 1.14 Bid Size 13,200.00 Ask 1.15 Ask Size 1,400.00
Open 1.14 High 1.18 Low 1.14 Prev Close 1.15
Last Trade Volume 65,569 52 Wk Hi 8.75 52 Wk Low 1.08
Market Cap 40.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,881,127.00 EPS (TTM) -0.02 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/11/18 03/11/18 03/11/18 03/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3